Deerfield Management Company, L.P. (Series C) Gh Research PLC Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Gh Research PLC stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 925,000 shares of GHRS stock, worth $11.7 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
925,000Holding current value
$11.7 Million% of portfolio
0.26%Shares
4 transactions
Others Institutions Holding GHRS
# of Institutions
42Shares Held
38.5MCall Options Held
5KPut Options Held
5.5K-
Bvf Inc San Francisco, CA8.83MShares$111 Million4.28% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.94MShares$87.6 Million1.59% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.44MShares$81.3 Million26.28% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$69.4 Million0.99% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$25.3 Million2.35% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $656M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...